Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Frappaz

Showing results (161-170 of 189) with videos related to

Pageof 19
Sort By:
Early Human Development|September 20, 1996
A 5-year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observationsP Mathieu, D Frappaz, F Chauvin, et al.
Medical and Pediatric Oncology|February 1, 1997
Screening for neuroblastoma in France: methodological aspects and preliminary observationsF Chauvin, P Mathieu, D Frappaz, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, O Delattre, O Hartmann, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|June 12, 2019
The European Society of Paediatric Oncology Ependymoma-II program Core-Plus model: Development and initial implementation of a cognitive test protocol for an international brain tumour trialS Thomas, D Reynolds, M C H J Morrall, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2018
Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 studyB Fresneau, D Orbach, C Faure-Conter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosisD Frappaz, J Michon, C Coze, et al.
Revue Neurologique|March 4, 2014
Patterns of care and survival of glioblastoma patients: a comparative study between 2004 and 2008 in Lyon, FranceN Badaoui, D Meyronet, S Cartalat-Carel, et al.
Journal of Neuro-Oncology|August 31, 2004
High and low grade oligodendrogliomas (ODG): correlation of amino-acid and glucose uptakes using PET and histological classificationsF Giammarile, L E Cinotti, A Jouvet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup StudyL S Lashford, P Thiesse, A Jouvet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE groupM C Favrot, P Ambros, F Schilling, et al.
Pageof 19

Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
Early Human Development|September 20, 1996
A 5-year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observationsP Mathieu, D Frappaz, F Chauvin, et al.
Medical and Pediatric Oncology|February 1, 1997
Screening for neuroblastoma in France: methodological aspects and preliminary observationsF Chauvin, P Mathieu, D Frappaz, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, O Delattre, O Hartmann, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|June 12, 2019
The European Society of Paediatric Oncology Ependymoma-II program Core-Plus model: Development and initial implementation of a cognitive test protocol for an international brain tumour trialS Thomas, D Reynolds, M C H J Morrall, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2018
Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 studyB Fresneau, D Orbach, C Faure-Conter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosisD Frappaz, J Michon, C Coze, et al.
Revue Neurologique|March 4, 2014
Patterns of care and survival of glioblastoma patients: a comparative study between 2004 and 2008 in Lyon, FranceN Badaoui, D Meyronet, S Cartalat-Carel, et al.
Journal of Neuro-Oncology|August 31, 2004
High and low grade oligodendrogliomas (ODG): correlation of amino-acid and glucose uptakes using PET and histological classificationsF Giammarile, L E Cinotti, A Jouvet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup StudyL S Lashford, P Thiesse, A Jouvet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE groupM C Favrot, P Ambros, F Schilling, et al.
Pageof 19